PDF (Język Polski)



How to Cite

Vierstra, L., & Pietrzak, A. (2021). Polski: English. Letters in Oncology Science, 17(4), 16-21. https://doi.org/10.21641/los.2020.17.4.190


Lung cancer is one of the most common oncological diseases worldwide. The critical element of the lung cancer patients’ management is an accurate and fast diagnosis. The radioisotope techniques of imaging can be helpful in the lung cancer diagnosis, however the sensitivity and the specificity depend on the type of used radiopharmaceutical.

PDF (Język Polski)


Krzakowski M, Jassem J, Antczak A. Nowotwory płuca i opłucnej oraz śródpiersia. OncolClinPract 2019; 15.

Szlitkus P. Epidemiologia nowotworu płuc w Polsce. Zeszyty Naukowe WCO, Letters in Oncology Science 2018;15(2):71-77.

Ogólnopolski Program Wczesnego Wykrywania Raka Płuca (WWRP) za Pomocą Niskodawkowej Tomografii Komputerowej (NDTK) – połączenie prewencji wtórnej z pierwotną w celu poprawy świadomości dotyczącej raka płuca wśród społeczeństwa i personelu ochrony zdrowia.

Gośliński J, Rak płuca w trzecim stopniu zaawansowania – nowe możliwości leczenia. Immunoonkologia, Katalog nowotworów, Leczenie nowotworów, Rak płuca.

Lim W, Ridge C A, Nicholson A G. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018 Aug; 8(7): 709–718.

Bradley S H, Abraham S, Callister M E. Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review. Br J Gen Pract. 2019 Nov 28;69(689):e827-e835.

E L, Lu L, Li L. Radiomics for Classifying Histological Subtypes of Lung Cancer Based on Multiphasic Contrast-Enhanced Computed Tomography. Journal of Computer Assisted Tomography, 01 Mar 2019, 43(2):300-306.

Kumar S, Liney G, Rai R. Magnetic resonance imaging in lung: a review of its potential for radiotherapy. Br J Radiol. April 2016; 89(1060): 20150431.

Greenspan B S. Role of PET/CT for precision medicine in lung cancer: perspective of the Society of Nuclear Medicine and Molecular Imaging. Transl Lung Cancer Res. 2017 Dec; 6(6): 617–620.

Dostęp w Internecie: IAEA, Nuclear science. Radioisotopes.

Payolla F B, Massabni A C, Orvig C. Radiopharmaceuticals for diagnosis in nuclear medicine: a short review. EcléticaQuímica, vol. 44, no. 3, 2019.

Szkliniarz K. Cyklotronowa produkcja i badanie radioizotopów stosowanych w diagnostyce i terapii medycznej. Rozprawa Doktorska, Katowice 2016.

Kane S M, Davis D D. Technetium-99m. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.

Kuśmierek J, Płachcińska A. Metody medycyny nuklearnej w diagnostyce chorób płuc.

Dai D, Rollo F D, Bryant J, Kim E E. Noninferiority of 99mTc-Ethylenedicysteine-Glucosamine as an Alternative Analogue to 18F-Fluorodeoxyglucose in the Detection and Staging of Non-Small Cell Lung Cancer. Contrast Media Mol Imaging. 2018; 2018: 8969714.

Jacobson O, Kiesewetter D O, Chen X.Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Route. Bioconjug Chem. 2015 Jan 21; 26(1): 1–18.

Hochhegger B, Alves G F, Irion K. PET/CT imaging in lung cancer: indications and findings. J Bras Pneumol. 2015 May-Jun; 41(3): 264–274.

Budak E, Çok G, Akgün A. The Contribution of Fluorine 18F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning. Mol Imaging RadionuclTher. 2018 Jun; 27(2): 73–80.

Jensen M M, Kjaer A. Monitoring of anti-cancer treatment with 18F-FDG and 18F-FLT PET: a comprehensive review of pre-clinical studies. Am J Nucl Med Mol Imaging. 2015; 5(5): 431–456.

Wang F, Tan Y, Gu X. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging. Chin Med J (Engl). 2016 Dec 20; 129(24): 2926–2935.

McGowan D R, Macpherson R E, Hackett S L. 18F‐fluoromisonidazole uptake in advanced stage non‐small cell lung cancer: A voxel‐by‐voxel PET kinetics study. Med Phys. 2017 Sep; 44(9): 4665–4676.

Xu Z, Li X, Zou H. 18F-Fluoromisonidazole in tumor hypoxia imaging. Oncotarget. 2017 Nov 7; 8(55): 94969–94979.

Jiang Y, Hou G, Cheng W. The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid. A systematic review and meta-analysis. Medicine (Baltimore). 2019 Mar; 98(10): e14769.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.


Download data is not yet available.